A practitioner of acupuncture in Dawson Creek, British Columbia, has been suspended for a period of two months following an investigation by a regulatory college. The inquiry revealed that the acupuncturist, Katie Johnston, prescribed ivermectin and fenbendazole, medications commonly used in animals but not authorized for human consumption by Health Canada.
The College of Complementary Health Professionals of B.C. initiated the investigation into Johnston’s actions in April 2025, which concluded with a consent order. The college determined that Johnston overstepped her regulated scope of practice by prescribing medications and recommending oral products within her clinic.
The college highlighted that Johnston failed to document prescription information and patient monitoring for those receiving fenbendazole and ivermectin. Additionally, she performed point injection therapies beyond her authorized practice and altered patient records post-receiving an investigation notice from the college.
Johnston admitted to engaging in misconduct, leading to her suspension for two months as per the consent order. She agreed to undergo professional courses on ethical conduct and record-keeping in healthcare. Furthermore, she consented to random audits of her acupuncture practice for the next year.
During the peak of the COVID-19 pandemic, there was a shortage of ivermectin in Canada amid misinformation suggesting its use for treating the virus. While safe for human use under proper medical supervision, ivermectin may have interactions with other medications or may not be suitable for individuals with specific health conditions.
